136-150 of 282
Systemic Hormonal Therapy Options for Post-Menopausal Patients
Clinician's RoundtableSystemic Hormonal Therapy Options for Post-Menopausal Patients
Prathima Setty, MD
Knee Replacement Procedures: When to Hold vs Refer Your Patients
Primary Care TodayKnee Replacement Procedures: When to Hold vs Refer Your Patients
Brian P. McDonough, MD, FAAFP
The Other Talk: A Guide to Talking with Your Adult Children About the Rest of Your Life
Book ClubThe Other Talk: A Guide to Talking with Your Adult Children About the Rest of Your Life
Maurice Pickard, MD
Sexuality in Elder Women: Why Physicians Need to Ask About It
Clinician's RoundtableSexuality in Elder Women: Why Physicians Need to Ask About It
Matt Birnholz, MD
Maurice Pickard, MD
Advocacy Updates from the Alzheimer's Association
Clinician's RoundtableAdvocacy Updates from the Alzheimer's Association
Paul Rokuskie
- advertisement
New Insights on Statin Therapy for Older Patients
Lipid LuminationsNew Insights on Statin Therapy for Older Patients
Alan S. Brown, MD, FACC, FAHA, FNLA
Attaining the Best Glucose Control Safely
Diabetes DiscourseAttaining the Best Glucose Control Safely
George Grunberger, MD, FACP, FACE
Farhad Zangeneh, MD
Alzheimer's Disease and the Key to Finding Better Treatments
Second Opinion LIVE!Alzheimer's Disease and the Key to Finding Better Treatments
Shellie Williams, MD
Reed Tuckson, MD
Matt Birnholz, MD
Michael Greenberg, MD
Eric Rackow, MD
Steven Edelman, MD
Lung Allocation and Who is Transplanted
Advances in TransplantationLung Allocation and Who is Transplanted
Aaron Carroll, MD
John M Reynolds, MD
University of Arizona - Preclinical Stage Alzheimer's Disease: Characterizing and Defining the Transition Between Normal and Pathological Cognitive Aging, Part 3
Grand Rounds Nation®University of Arizona - Preclinical Stage Alzheimer's Disease: Characterizing and Defining the Transition Between Normal and Pathological Cognitive Aging, Part 3
Matt Birnholz, MD
- advertisement
University of Arizona - Preclinical Stage Alzheimer's Disease: Characterizing and Defining the Transition Between Normal and Pathological Cognitive Aging, Part 2
Grand Rounds Nation®University of Arizona - Preclinical Stage Alzheimer's Disease: Characterizing and Defining the Transition Between Normal and Pathological Cognitive Aging, Part 2
Matt Birnholz, MD
University of Arizona - Preclinical Stage Alzheimer's Disease: Characterizing and Defining the Transition Between Normal and Pathological Cognitive Aging, Part 1
Grand Rounds Nation®University of Arizona - Preclinical Stage Alzheimer's Disease: Characterizing and Defining the Transition Between Normal and Pathological Cognitive Aging, Part 1
Matt Birnholz, MD
Venous Thromboembolism Management and Antithrombotic Therapy in Long-Term Care
Advances in Long Term Care MedicineVenous Thromboembolism Management and Antithrombotic Therapy in Long-Term Care
Thiruvinva Dharmarajan, MD FACP AGSF
Eric Tangalos, MD